205 related articles for article (PubMed ID: 27831566)
21. Dietary modification dampens liver inflammation and fibrosis in obesity-related fatty liver disease.
Larter CZ; Yeh MM; Haigh WG; Van Rooyen DM; Brooling J; Heydet D; Nolan CJ; Teoh NC; Farrell GC
Obesity (Silver Spring); 2013 Jun; 21(6):1189-99. PubMed ID: 23666886
[TBL] [Abstract][Full Text] [Related]
22. SIRT1 regulates TNF-α-induced expression of CD40 in 3T3-L1 adipocytes via NF-κB pathway.
Lin QQ; Yan CF; Lin R; Zhang JY; Wang WR; Yang LN; Zhang KF
Cytokine; 2012 Nov; 60(2):447-55. PubMed ID: 22717288
[TBL] [Abstract][Full Text] [Related]
23. Inflammatory NF-kappaB activation promotes hepatic apolipoprotein B100 secretion: evidence for a link between hepatic inflammation and lipoprotein production.
Tsai J; Zhang R; Qiu W; Su Q; Naples M; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1287-98. PubMed ID: 19342510
[TBL] [Abstract][Full Text] [Related]
24. Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells.
Morán-Salvador E; Titos E; Rius B; González-Périz A; García-Alonso V; López-Vicario C; Miquel R; Barak Y; Arroyo V; Clària J
J Hepatol; 2013 Nov; 59(5):1045-53. PubMed ID: 23831119
[TBL] [Abstract][Full Text] [Related]
25. Serum Amyloid A Induces Inflammation, Proliferation and Cell Death in Activated Hepatic Stellate Cells.
Siegmund SV; Schlosser M; Schildberg FA; Seki E; De Minicis S; Uchinami H; Kuntzen C; Knolle PA; Strassburg CP; Schwabe RF
PLoS One; 2016; 11(3):e0150893. PubMed ID: 26937641
[TBL] [Abstract][Full Text] [Related]
26. Relevance of SIRT1-NF-κB Axis as Therapeutic Target to Ameliorate Inflammation in Liver Disease.
de Gregorio E; Colell A; Morales A; Marí M
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485811
[TBL] [Abstract][Full Text] [Related]
27. Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion.
Wu Y; Liu X; Zhou Q; Huang C; Meng X; Xu F; Li J
Toxicol Appl Pharmacol; 2015 Dec; 289(2):163-76. PubMed ID: 26435214
[TBL] [Abstract][Full Text] [Related]
28. The histone methyltransferase Suv39h2 contributes to nonalcoholic steatohepatitis in mice.
Fan Z; Li L; Li M; Zhang X; Hao C; Yu L; Zeng S; Xu H; Fang M; Shen A; Jenuwein T; Xu Y
Hepatology; 2017 Jun; 65(6):1904-1919. PubMed ID: 28244120
[TBL] [Abstract][Full Text] [Related]
29. Hepatic Knockdown of Splicing Regulator Slu7 Ameliorates Inflammation and Attenuates Liver Injury in Ethanol-Fed Mice.
Wang J; Kainrad N; Shen H; Zhou Z; Rote P; Zhang Y; Nagy LE; Wu J; You M
Am J Pathol; 2018 Aug; 188(8):1807-1819. PubMed ID: 29870742
[TBL] [Abstract][Full Text] [Related]
30. The peroxisome proliferator-activated receptor γ agonist pioglitazone prevents NF-κB activation in cisplatin nephrotoxicity through the reduction of p65 acetylation via the AMPK-SIRT1/p300 pathway.
Zhang J; Zhang Y; Xiao F; Liu Y; Wang J; Gao H; Rong S; Yao Y; Li J; Xu G
Biochem Pharmacol; 2016 Feb; 101():100-11. PubMed ID: 26673543
[TBL] [Abstract][Full Text] [Related]
31. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells.
Paik YH; Schwabe RF; Bataller R; Russo MP; Jobin C; Brenner DA
Hepatology; 2003 May; 37(5):1043-55. PubMed ID: 12717385
[TBL] [Abstract][Full Text] [Related]
32. Paeonol alleviated acute alcohol-induced liver injury via SIRT1/Nrf2/NF-κB signaling pathway.
Sun X; Wang P; Yao LP; Wang W; Gao YM; Zhang J; Fu YJ
Environ Toxicol Pharmacol; 2018 Jun; 60():110-117. PubMed ID: 29704732
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of HMGB1 release via salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease.
Zeng W; Shan W; Gao L; Gao D; Hu Y; Wang G; Zhang N; Li Z; Tian X; Xu W; Peng J; Ma X; Yao J
Sci Rep; 2015 Nov; 5():16013. PubMed ID: 26525891
[TBL] [Abstract][Full Text] [Related]
34. MCPIP1 alleviated lipopolysaccharide-induced liver injury by regulating SIRT1 via modulation of microRNA-9.
Han S; Li Z; Ji P; Jia Y; Bai X; Cai W; Li X; Yang C; Yang Y; Yang K; Wu G; Zhang W; Hu D
J Cell Physiol; 2019 Dec; 234(12):22450-22462. PubMed ID: 31099043
[TBL] [Abstract][Full Text] [Related]
35. Quercetin attenuates the activation of hepatic stellate cells and liver fibrosis in mice through modulation of HMGB1-TLR2/4-NF-κB signaling pathways.
Li X; Jin Q; Yao Q; Xu B; Li Z; Tu C
Toxicol Lett; 2016 Nov; 261():1-12. PubMed ID: 27601294
[TBL] [Abstract][Full Text] [Related]
36. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.
Park EJ; Kim YM; Kim HJ; Jang SY; Oh MH; Lee DH; Chang KC
Eur J Pharmacol; 2016 Oct; 788():200-209. PubMed ID: 27343380
[TBL] [Abstract][Full Text] [Related]
37. Selective inactivation of NF-kappaB in the liver using NF-kappaB decoy suppresses CCl4-induced liver injury and fibrosis.
Son G; Iimuro Y; Seki E; Hirano T; Kaneda Y; Fujimoto J
Am J Physiol Gastrointest Liver Physiol; 2007 Sep; 293(3):G631-9. PubMed ID: 17640975
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia-inducible factor-2 promotes liver fibrosis in non-alcoholic steatohepatitis liver disease via the NF-κB signalling pathway.
Cai H; Bai Z; Ge RL
Biochem Biophys Res Commun; 2021 Feb; 540():67-74. PubMed ID: 33450482
[TBL] [Abstract][Full Text] [Related]
39. Progranulin attenuates liver fibrosis by downregulating the inflammatory response.
Yoo W; Lee J; Noh KH; Lee S; Jung D; Kabir MH; Park D; Lee C; Kwon KS; Kim JS; Kim S
Cell Death Dis; 2019 Oct; 10(10):758. PubMed ID: 31591383
[TBL] [Abstract][Full Text] [Related]
40. SIRT1 expression is refractory to hypoxia and inflammatory cytokines in nucleus pulposus cells: Novel regulation by HIF-1α and NF-κB signaling.
Wang X; Li H; Xu K; Zhu H; Peng Y; Liang A; Li C; Huang D; Ye W
Cell Biol Int; 2016 Jun; 40(6):716-26. PubMed ID: 27061137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
